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Traumatic brain injury (TBI) is a major health problem worldwide. In addition to
its high mortality (35–40%), survivors are left with cognitive, behavioral, and
communicative disabilities. While little can be done to reverse initial primary brain
damage caused by trauma, the secondary injury of cerebral tissue due to cerebro-
microvascular alterations and dysregulation of cerebral blood flow (CBF) is
potentially preventable. This review focuses on functional, cellular, and molecular
changes of autoregulatory function of CBF (with special focus on cerebrovascular
myogenic response) that occur in cerebral circulation after TBI and explores the
links between autoregulatory dysfunction, impaired myogenic response, microvas-
cular impairment, and the development of secondary brain damage. We further
provide a synthesized translational view of molecular and cellular mechanisms
involved in cortical spreading depolarization-related neurovascular dysfunction,
which could be targeted for the prevention or amelioration of TBI-induced sec-
ondary brain damage.
autoregulation; neurovascular coupling; brain damage; myogenic; cerebral blood
flow
TRAUMATIC BRAIN INJURY (TBI) occurs when the head is hit
directly or indirectly by an object (e.g., during a fall or a traffic
accident) or by blast waves, or when an object (e.g., a projec-
tile) pierces the skull and enters the brain parenchyma. Each
year 1.7 million people in the United States (81, 123, 136)
and another 2.5 million patients in the European Union (136)
suffer TBI. In addition to a high mortality rate (35–40%),
survivors of severe TBI and patients suffering mild but repet-
itive trauma are left with significant cognitive, behavioral,
and communicative disabilities imparting an even larger
burden to the health care systems (123) and the families of
these victims. Epidemiological studies show that 5.3 mil-
lion people live with TBI-related disabilities in the United
States (81) and 7.7 million in the European Union (136).
Pediatric and elderly populations are the most vulnerable,
and specific subpopulations (e.g., military workers, athletes,
such as boxers, football and hockey players, jumpers, skat-
ers) are frequently exposed to repetitive head trauma (24).
TBI can be mild, moderate, or severe defined by clinical
appearance (decrease or loss of consciousness, loss of mem-
ory before or after an event, neurological deficit, alteration
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in mental state at the time of the injury), imaging findings, and
various biomarkers (99).
While little can be done to reverse the initial primary brain
damage caused by trauma, the secondary brain injury (in part)
due to vascular/microvascular alterations, and dysregulation of
cerebral blood flow (CBF) initiated by TBI is potentially
preventable. TBI affects practically all tissue and cell types
directly or indirectly involved in the regulation of CBF [endo-
thelial cells, astrocytes, pericytes, the blood-brain barrier
(BBB), structure of the vascular wall and perivascular inner-
vation, onset of microhemorrhages, etc.], leading to traumatic
cerebrovascular injury (73, 76). A detailed description of these
divergent cerebrovascular consequences of TBI is beyond the
scope of the present discussion. In this review the effect of TBI
is considered for two unique mechanisms of regulation of CBF:
1) autoregulation of CBF and 2) neurovascular coupling in
terms of potential mechanisms and pathophysiological conse-
quences. The possible benefits of emerging therapeutic strate-
gies that have the potential to restore vascular and microvas-
cular function and prevent secondary brain ischemia are also
briefly discussed.
IMPAIRED AUTOREGULATION OF CBF AFTER TBI
Autoregulation of CBF and Pathophysiological
Consequences of Autoregulatory Dysfunction
The regulation of cerebral circulation has to comply with
special requirements. First, cerebral tissue is very sensitive to
hypoxia/ischemia and therefore requires a stable and continu-
ous supply of nutrients and oxygen for normal neuronal func-
tion. Second, because the brain is enclosed in the cranium,
uncontrolled vasodilation/engorgement would lead to pressure
and volume overload of the circulation and an increases in
intracranial pressure (ICP). Among others, the two main reg-
ulatory mechanisms responsible for meeting these require-
ments are: 1) pressure-induced vasomotor autoregulation pre-
venting free transmission of changes in systemic blood pres-
sure to changes in CBF and 2) neurovascular coupling
adjusting CBF to the metabolic needs of active neuronal/glial
tissues.
CBF has to be relatively constant to provide a continuous
and stable blood flow to brain tissue despite changes in sys-
temic blood pressure and thus cerebral perfusion pressure
(CPP;  systemic blood pressure  ICP), yet allowing heter-
ogeneity in CBF distribution and local functional hyperemia
according to the increased neural/glial function. The mecha-
nism fulfilling these requirements is called autoregulation of
CBF. Autoregulation of CBF is the integration of myogenic
(pressure-induced), metabolic, and sympathetic mechanisms
(details provided in Mechanisms of Autoregulatory Dysfunc-
tion after TBI) (78, 82). These mechanisms adjust the diameter
of cerebral resistance vessels and thus cerebrovascular resis-
tance (CVR) to the changes of perfusion pressure: they increase
CVR in case of increasing perfusion pressure and decrease it
when blood pressure drops. In other words, cerebral autoregula-
tion is a negative feedback process maintaining stable and con-
stant blood flow when perfusion pressure changes: 1) in hypo-
tension an intact autoregulation prevents hypoperfusion and
ischemia of cerebral tissue; and 2) in hypertension it protects
the cerebral microvascular bed against hyperemia and hyper-
volemia (Fig. 1). Mechanisms of CBF autoregulation include
static and dynamic components. Static autoregulation of CBF
adjusts vascular resistance (thus blood flow) to a steady-state
perfusion pressure value, and it dictates how large changes in
perfusion pressure can be compensated. Dynamic cerebral
autoregulation restores CBF after rapid transient changes in
perfusion pressure and thus determines how fast the autoreg-
ulatory compensation can be implemented. Dynamic and static
cerebral autoregulation act on a continuum to maintain CBF
when blood pressure changes. Regarding methods to measure
autoregulation we refer to other detailed reviews and classical
studies of the field (1, 83–85, 113, 129, 143, 151).
As mentioned above, when autoregulatory mechanisms, due
to their impaired capacity to decrease cerebrovascular resis-
tance, cannot maintain approximately unchanged cerebral per-
fusion when blood pressure decreases, then autoregulatory
dysfunction leads to ischemia of cerebral tissue. On the con-
trary, at high pressure values, the significance of autoregulatory
mechanisms responsible for maintaining constant blood flow
can be appreciated when taking into account the anatomical
fact that the brain is situated in the closed cranium consisting
of three main volume compartments: cerebral tissue, cerebro-
spinal fluid, and intravascular blood. Volume expansion of one
of the compartments can only be compensated by a decrease in
the others, as stated in the Kellie-Monroe doctrine and its
modified versions (101). Thus, in case of low intracranial
compliance (when compensatory capacity of CSF dynamics is
Fig. 1. Scheme illustrating the consequences of autoregulatory dysfunction
after traumatic brain injury (TBI). When autoregulatory function is intact (green
line) despite changes of perfusion pressure [PP: systemic blood pressure 
intracranial pressure (IP)] cerebral blood flow (CBF) is maintained at a near
constant level. (Please note that the transient drop in basal CBF following TBI
is not depicted.) The proposed model predicts that, following TBI, autoregu-
lation of CBF is compromised; thus, CBF passively changes as a function of
PP. When PP decreases, autoregulatory dysfunction results in significant
hypoperfusion and cerebral ischemia. In contrast, when PP increases, autoreg-
ulatory dysfunction results in cerebral hyperperfusion, leading to increased
intracranial pressure. These mechanisms lead to the formation of cytotoxic and
vasogenic edema. The resulting decline in oxygen and nutrient supply con-
tributes to secondary injury of cerebral tissue, increasing mortality and com-
promising functional recovery after TBI.
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attenuated), an uncontrolled increase in cerebral blood volume
(which is the only compartment with higher pressure than
normal or even pathological ICP) would lead to sudden in-
creases in ICP and may damage the cerebral microcirculation
(25, 26). This pathophysiological mechanism can be observed,
for example, in hypertensive encephalopathy (116) and in aged
mice not able to adapt to hypertension (140, 141). A similar
pathophysiological role of autoregulatory dysfunction and con-
sequent vascular engorgement after TBI in the development of
edema formation and elevation of ICP is a matter of ongoing
debate. In case of brain trauma, theoretically, ICP can be
increased either by edema of cerebral tissue or by enhanced
cerebrovascular volume (CBV).
Cerebral edema is classified to be either vasogenic or
cytotoxic. In case of vasogenic edema (mostly due to BBB
disruption) interstitial fluid accumulates after extravasation.
Cytotoxic edema develops following TBI when the meta-
bolic needs of cerebral tissue and nutrient delivery are not
met. This situation is usually caused by neuronal hyperme-
tabolism after TBI together with a permanent drop in basal
CBF (90). Because of the lack of energy in maintaining
ionic gradients, membrane potential is reduced or lost in
neurons, which results in depolarization and activation of
voltage-gated Ca2 channels. This then leads to glutamate
release and subsequent Ca2 influx, which will result in K
efflux from neurons and entering of Na and Cl together
with water (50).
The pioneering work of Marmarou et al. showed that, in
patients after severe TBI, 1) increased water content of the
brain is responsible for increased ICP rather than increased
CBV (91) 2) and the increased cerebral water is primarily due
to cytotoxic edema and only in part to vasogenic edema (92).
They also demonstrated that CBV decreased after TBI. How-
ever, 1) they studied the patients a few hours after the injury,
so it is not clear whether or not autoregulatory dysfunction and
consequent hypervolemia contribute to the rise in ICP acutely,
right after trauma. 2) It is also possible that once cytotoxic
edema is developed low CBV is a consequence of the space-
occupying effect of intracellular water (especially when blood
pressure is in the normal range). From this point of view
autoregulatory dysfunction and “vasoparalysis” can be a com-
pensatory mechanism to preserve normal ICP. 3) It is also not
known what occurs in case of severely elevated systemic blood
pressure, when autoregulation should prevent high pressure
and volume reaching the brain. Theoretically, in this case,
uncontrolled increase in CBV should further enhance cytotoxic
edema-induced high ICP. 4) Finally, lack of autoregulatory
protection would lead to increased wall tension when blood
pressure increases, which has been shown to exacerbate vas-
cular oxidative stress in cerebral arteries (130). Cerebrovascu-
lar oxidative stress impairs key mechanisms of regulation of
CBF, such as endothelial function and neurovascular coupling
(139). The importance of this possibility is underlined by our
recent study showing that neurovascular uncoupling alone,
without any other circulatory or neuronal changes, is capable
of causing cognitive deficit in mice (137). Neurovascular
dysfunction is also considered to be a central mechanism of
cognitive decline and dementia due to hypertension, aging, and
even Alzheimer’s disease (43, 114).
TBI-Induced Autoregulatory Dysfunction in Humans
Clinical studies provide ample evidence that both severe and
mild TBI impair static and dynamic autoregulation of CBF in
response to both decreasing and increasing perfusion pressure
in adults and children (23, 25, 26, 38, 39, 75, 103, 104, 107,
111). In the late 1990s (25) and around the year 2000, Czos-
nyka et al. provided further important evidence of disturbed
cerebral autoregulation following TBI (25, 26). Using a dy-
namic approach, they correlated blood flow velocity changes in
middle cerebral arteries (MCAs) of patients with spontaneous
slow fluctuations in CPP generating a correlation coefficient
(Mx) indicative of autoregulatory function: positive values of
Mx indicate a correlation between perfusion pressure and
blood flow velocity showing passive dependence of CBF on
CPP and therefore impaired autoregulation. Similarly, a mov-
ing correlation coefficient between spontaneous fluctuations in
arterial blood pressure and intracranial pressure can be gener-
ated (pressure reactivity index, PRx), which indicates intact
autoregulatory function when negative or zero values are
shown (blood pressure fluctuations are not transmitted to fluc-
tuations in ICP) (20). Because transmission of blood pressure
to changes in ICP are determined by the changes of CVR
evoked by changes in intraluminal pressure, PRx is a useful
clinical measure to observe and describe pressure-induced
myogenic responses of the cerebrovasculature. PRx and Mx
correlate with each other being two distinct measures of the
same mechanisms. In these studies, the averaged flow veloci-
ties over perfusion pressure values converged to the shape of
the known autoregulatory curve with the lower limit being
CPP 55 mmHg and upper limit CPP 105 mmHg. In other
words, the upper limit of autoregulation in TBI patients is
lower than the physiological value (150 mmHg). They also
found that autoregulation was disturbed in patients with high
ICP (25 mmHg) and low arterial pressure (75 mmHg).
Although increased Mx, PRx, and ICP were associated with
“unfavorable” outcomes (moderate disability), from these re-
sults it is not clear if disturbed autoregulation plays a causal
role in the rise of ICP or vice versa. In addition, linking
autoregulatory function to secondary injury PRx distinguished
between fatal and nonfatal outcomes.
It is very important to note that the onset of autoregulatory
dysfunction after TBI is not mandatory; autoregulatory func-
tion can be intact following TBI (50–90% of severe TBI
patients have diminished or absent autoregulatory function)
(80, 117, 144). As described above, in autoregulatory dysfunc-
tion, an optimal value of perfusion pressure can be defined, at
which autoregulation functions. Further studies should place a
greater emphasis in establishing and understanding the under-
lying mechanisms of this heterogeneity.
As mentioned above, autoregulatory dysfunction can also be
caused by mild TBI (144). Its importance might be best
appreciated in chronic repetitive mild brain trauma, which has
been demonstrated to lead to the development of chronic
traumatic encephalopathy (CTE) characterized by cognitive
and psychiatric problems. The histological hallmark of the
disease is the perivascular aggregation of the tau protein with
prominent perivascular spaces (15, 97), in addition to chronic
traumatic cerebrovascular injury (among others the phenotypic
changes of the BBB including the increase of perivascular
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matrix proteins fibronetctin and perlecan and accumulation of
amyloid  due to disturbed perivascular drainage) (72–74).
In addition to the mentioned mechanisms Bailey et al.
provided important evidence that autoregulatory dysfunction is
also involved in the pathology of CTE. They found that
dynamic autoregulation of CBF is impaired in professional
male boxers compared with age- and physical fitness-matched
male nonboxers that was associated with frontotemporal neu-
rocognitive dysfunction and the volume and intensity of spar-
ring, during which most of the mild head trauma occurred.
They also demonstrated a more marked orthostatic hypotension
in boxers, which can lead to transient cerebral hypoperfusion
due to the lack of autoregulatory compensation (14). Autoreg-
ulatory dysfunction may also participate in the development of
postconcussive symptoms after nonrepetitive mild TBI in the
pediatric population (15).
Autoregulatory Dysfunction in Animal Models of TBI
Experimental studies provided further evidence for TBI-
induced autoregulatory dysfunction, corroborating the clinical
findings. Lewelt et al. (88) applied low (1.5–2.2 atmospheres)
and severe (2.8–4.8 atmospheres) fluid percussion injuries on
cats and measured CBF after impact using the hydrogen
clearance technique in response to decreasing blood pressure
achieved by bleeding of the animals. They observed intact
autoregulatory responses in three out of eight cats in the
low-pressure trauma group. In the severe group, three out of
eight cats had no autoregulatory function: CBF decreased as a
function of blood pressure. Two animals maintained CBF until
100 mmHg, and the remaining maintained CBF until 80
mmHg, indicating impaired but partly preserved autoregula-
tory function (heterogeneity of autoregulatory dysfunction af-
ter TBI). DeWitt et al. also confirmed these findings in cats
(30). Similar results were obtained in rats (40) using laser
Doppler flowmetry demonstrating impaired autoregulatory re-
sponse to bleeding-induced hypotension 24 h after impact-
acceleration injury.
A rat study from Fujita et al. observing direct arteriolar
dilation also showed that the autoregulatory response to reduc-
tion in blood pressure is impaired after impact acceleration and
lateral fluid percussion injuries (48). Extending these findings,
Nawashiro et al. showed that impact acceleration injury also
disrupts autoregulatory function in response to increases in
blood pressure (106). On the contrary, however, Bedell et al.
reported (16) that CBF response to hypotension after a para-
sagittal fluid percussion injury in Sprague-Dawley rats does not
change and is not affected by hypothermia. Although the
presented data show no significant difference between the
groups, the mean arterial pressure-CBF curve of the injured
rats trended toward a steeper curve than control rats, and the
use of isoflurane anesthesia (known to dilate cerebral vessels)
may have influenced the results.
In summary, human and experimental studies provided ev-
idence that TBI heterogeneously impairs autoregulation of
CBF, which is associated with both unfavorable and fatal
outcomes (20, 25, 26, 71). Dysfunctional autoregulation has
bidirectional consequences: it results in ischemia with rela-
tively small reductions in blood pressure (thus increasing
cytotoxic edema) and permits marked increases in CBF with
modest increases in blood pressure (see Fig. 1). Although
cytotoxic edema seems to be the primary factor in TBI-related
development of cerebral edema formation and in the increases
of ICP, autoregulatory dysfunction-related increase in CBV
may increase microvascular volume and exacerbate extravasa-
tion when the BBB is disrupted (BBB disruption is most likely
permissive for the development of autoregulatory dysfunction-
related edema formation because an intact BBB is capable of
preventing the extravasation of intraluminal fluid by active
osmotic compensatory mechanisms, even during severely in-
creased hydrostatic pressure in the arteriolar and capillary bed)
(54). It is also possible that a bidirectional pathological link
exists: autoregulatory dysfunction likely promotes pressure-
induced injury to the microvascular endothelial cells, leading
to disruption of the BBB (140). This concept is supported by
the findings that mannitol is less effective in reducing ICP
when autoregulation is impaired (103). Regarding the cellular
and molecular mechanisms of TBI-induced microvascular in-
jury and BBB disruption, we refer to other recent reviews (2,
3). When blood pressure is above the normal range, autoreg-
ulatory dysfunction, by allowing greater blood volume and
pressure to enter the brain, may enhance cytotoxic edema-
related increased ICP. Pathological consequences of the dys-
function of mechanisms maintaining the upper part of the
autoregulatory curve after TBI need further studies both in
humans and animal models.
Mechanisms of Autoregulatory Dysfunction after TBI
Role of impaired pressure-induced myogenic response in
autoregulatory dysfunction associated with TBI. The purpose
of autoregulation is to adjust CVR in response to changes in
perfusion pressure to maintain a nearly constant CBF. Cerebral
arterial vessels actively dilate and constrict when blood pres-
sure decreases or increases, respectively. This pressure-in-
duced myogenic response plays a central role in CBF autoreg-
ulation (11, 17, 18, 22, 42, 45, 47, 49, 57, 59, 95, 96, 98, 102,
110, 140, 146). Several studies demonstrated that TBI impairs
both myogenic dilation and constriction of cerebral resistance
vessels (Fig. 2). The myogenic function of cerebral vessels can
be studied in vivo by observing the responses of pial arteries
and arterioles through a cranial window in response to changes
in blood pressure (48) or ex vivo by using pressure myography
(138). The latter approach when using isolated vessels has the
advantage that primary impairment of pressure-induced intrin-
sic vascular responses can be identified without the confound-
ing effects of factors produced by neurons and glia after TBI.
Previous studies using pressure myography showed that
isolated MCA of rats exhibit impaired myogenic dilation in
response to decreases in perfusion pressure after severe con-
trolled cortical impact. This observation supports the concept
that TBI primarily impairs vasomotor mechanisms intrinsic to
the vascular wall. The findings that TBI-induced impairment is
present on both the ipsilateral (2 and 24 h after impact) and the
contralateral side (24 h after the impact) (51) suggest that TBI
leads to a generalized vasomotor dysfunction in the cerebral
microcirculation. Similarly, decreased myogenic dilation can
also be demonstrated in isolated rat MCAs shortly after fluid
percussion injury (93).
Recent studies (145) showed that, in isolated rat MCAs,
myogenic constriction is also decreased after moderate fluid
percussion and severe weight-drop injury (Fig. 2). Although
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the clinical importance of these observations was demonstrated
by Budohoski et al. showing that negative or zero pressure
reactivity index [which is a surrogate of intact cerebrovascular
myogenic function (vide supra)] correlates with both intact
autoregulatory function and better outcome in TBI patients
(20), the molecular mechanisms of the TBI-related impairment
of cerebral myogenic function are less known.
Cellular mechanisms of impaired myogenic dilation of ce-
rebral vessels after TBI. The mechanisms of impaired myo-
genic dilation of cerebral vessels after TBI are likely multifac-
eted. TBI induces excessive production of vascular nitric oxide
(NO) (126, 145) and accumulation of (in part NADPH oxidase-
derived) reactive oxygen species (ROS), such as O2
 (77) (Fig.
3). These processes together lead to the production of per-
oxynitrite (ONOO) (29). In both endothelial and smooth
muscle cells, ONOO was shown to inhibit vascular Ca2-
activated K (BK) channels (19), thus causing constriction of
cerebral arteries (37). Because BK channels were demonstrated
to contribute to myogenic dilation (13), this mechanism is
likely to be involved in TBI-related impairment of myogenic
dilation. An interesting study from Yu et al. showed that
scavenging TBI-induced production of ONOO restores myo-
genic dilation of rat MCAs via improving gap junction com-
munication between smooth muscle cells (150). Prostaglan-
dins, especially PGE2, have been demonstrated to contribute to
dilation of pial arteries in response to hypotension, which is
disturbed by fluid-percussion injury in newborn pigs (7). How-
ever, findings of Dabertrand et al. make these results contro-
versial, providing substantial evidence that isolated cerebral
arterioles of rats and mice constrict, rather than dilate, to PGE2
administration (27). It has to be noted that responses of human
cerebral arterioles to PGE2 administration are not known.
Another interesting possibility is the role of TBI-induced
production of tissue plasminogen activator (tPA). Armstead et
al. showed that, in a newborn pig, an inactive tPA variant
(tPA-S481A) prevents the impairment of autoregulation when
administered 30 min after fluid percussion injury (FPI) by
inhibiting overactivation of N-methyl-D-aspartate (NMDA) re-
ceptors. TBI results in increased production of the vasocon-
strictor endothelin-1 (ET-1), and tPA-S481A also inhibits the
ET-1 receptor (8). In addition, ET-1 antagonizes NMDA re-
ceptor-mediated vasodilation (6) and leads to impaired dilation
of cerebral vessels mediated by K channel agonists after FPI,
via release of superoxide anion. The role of ROS is also
suggested by studies of Kim et al. showing that arteriolar
dilation to hypotension after FPI was restored by both 1) the
transfer of human copper-zinc superoxide dismutase in rats via
intracisternal administration of recombinant adenoviruses, and
2) treatment of the pial circulation with the NADPH oxidase
inhibitor diphenyleneiodonium (77). On the other hand, ROS
production may play a beneficial role in preserving dilator capac-
ity of cerebral vessels: an interesting study of Sullivan et al.
demonstrated that NADPH oxidase 2-derived ROS activate Ca2-
permeable transient receptor potential ankyrin 1 (TRPA1) chan-
nels on the cerebrovascular endothelium leading to Ca2 influx.
These Ca2 “sparklets” activated intermediate-conductance
Ca2-sensitive K channels leading to hyperpolarization of
vascular smooth muscle and dilation of vessels (134). Future
studies should examine the effects of the pharmacological
and/or genetic activation of TRPA1/intermediate-conductance
Ca2-sensitive K channels on cerebrovascular tone following
TBI.
Cellular mechanisms of impaired myogenic constriction of
cerebral vessels after TBI. The vascular processes leading to
the impairment of myogenic constriction of cerebral vessels
Fig. 3. Proposed mechanisms underlying impaired myogenic autoregulatory
protection after TBI: TBI-induced decreased myogenic dilation. TBI impairs
the capability of cerebral vessels to dilate (thus to decrease cerebrovascular
resistance) when PP drops. For detailed description of these pathways we refer
to the text. BKCa, large-conductance Ca2-activated K channel; COX-2,
cyclooxygenase-2; PGE2, prostaglandin E2; NADPH ox, NADPH oxidase; GJ,
gap junction; ONOO, peroxynitrite; iNOS, inducible nitric oxide synthase;
NO, nitric oxide; NMDA, N-methyl-D-aspartate; NMDAr, N-methyl-D-aspar-
tate receptor; ET-1, endothelin-1; ET-1r, endothelin-1 receptor; tPA, tissue
plasminogen activator.
Fig. 2. TBI impairs myogenic response of cerebral arteries. Redrawn original
recordings of changes of inner diameters of isolated middle cerebral arteries
(MCA) from sham-operated rats and rats 24 h after severe TBI (caused by the
weight-drop method) using pressure myography (138). Please note that the
MCA develops an active tone in response to increasing PP in control animals,
and this myogenic response overlaps the range of autoregulation of CBF.
Myogenic response is absent 24 h after the animal suffered severe TBI. Passive
properties of the vessels did not differ between control and TBI rats.
PD80mmHg, passive diameter at 80 mmHg.
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following brain trauma are less understood (Fig. 4). As men-
tioned above, TBI induces excessive production of NO both in
cerebral/glial tissue and in the cerebrovasculature (126, 145).
NO was shown to contribute to the initial increase in CBF 30
min after trauma (126), and inhibition of NO with VAS203
decreased ICP in mice (125). Based on these initial findings,
Villalba et al. (145) tested the hypothesis that increased vas-
cular NO is responsible for the absence of myogenic constric-
tion of cerebral vessels after TBI. They found that 24 h after
FPI of rats myogenic constrictions were diminished in both the
ipsilateral and contralateral MCAs studied in a myograph
chamber. The authors also demonstrated that production of NO
was greatly increased in both the endothelial and smooth
muscle layers of MCAs after TBI and that inhibition of NO
production with NG-nitro-L-arginine increased myogenic tone
of the impacted vessels.
Along with these functional data they showed that TBI
enhanced vascular expression of inducible nitric oxide syn-
thase (iNOS). They also showed that constrictions after inhi-
bition of guanylyl cyclase, protein kinase G (PKG), and BK
channels were decreased in animals after trauma. Based on
these findings, the authors proposed that TBI triggers endothe-
lial production of iNOS-derived NO, which then decreases
pressure-induced smooth muscle Ca2 concentration due to
hyperpolarization after the cGMP/PKG-dependent activation
of BK channels (145). Although the effect of inhibition of NO
production on the myogenic response of MCAs is convincing,
after the treatment, myogenic tone seems to be lower at 80 and
100 mmHg compared with control vessels, and the pressure
range over 100 mmHg is not covered by the study. Thus it is
not clear if NO is responsible for the loss of myogenic
constriction at higher pressure values and whether NO has a
permissive or a direct role in the impairment of the pressure-
induced constriction. In other words: is NO produced in re-
sponse to pressure after TBI?
Although the vascular endothelium is capable of modulating
vascular myogenic tone (for example, flow-induced dilation
attenuates pressure-induced constriction when flow and pres-
sure change simultaneously) (142), it is not thought to contrib-
ute to myogenic constriction, and this would support a permis-
sive role (for a review on the topic, please see Ref. 28). The
vessels did not constrict to the thromboxane analog U-46619 or
to K, as they did in controls, indicating that MCAs lost their
ability to constrict to agonists beyond the effect of pressure-
induced constriction. This would further support the permis-
sive indirect role of NO in the defective myogenicity of
cerebral vessels after TBI. It also further complicates the
notion that, after TBI, ONOO is formed from NO, which is a
known constrictor of cerebral vessels. Downstream signaling
from NO in myogenic constriction after TBI is also in question,
since the authors showed constriction to the inhibitors of the
mentioned targets instead of the restoration of the myogenic
response in the presence of these drugs.
Neurogenic and metabolic effects on autoregulatory func-
tion following TBI. In addition to the pressure-induced myo-
genic response of cerebral vessels, other factors are involved in
setting CVR during changes in perfusion pressure. Accord-
ingly, neurogenic (sympathetic) and metabolic factors were
suggested to contribute to CBF autoregulation, but their role in
TBI-induced autoregulatory dysfunction is less known (55). In
newborn pigs following FPI, administration of norepinephrine
prevented CBF reductions in response to decreasing blood
pressure via the inhibition of mitogen-activated protein kinases
(MAPKs) and probably via increasing perfusion pressure (10).
Another interesting study also from Armstead et al. (9) dem-
onstrated that, in piglets, glucagon treatment (known to de-
crease neuronal glutamate release after TBI) together with the
mentioned inhibition of tPA fully restored hypotension-in-
duced pial arterial dilation after FPI via decreased ERK MAPK
and NMDA and increased PGE2-PGI2 levels. Neuronal metab-
olism is increased after trauma and, together with the acutely
decreased basal blood flow, leads to a mismatch between the
increased metabolic demand and nutrient supply (46). Al-
though the increased lactate levels are capable of modulating
cerebrovascular tone and thus autoregulatory function, the
consequent direct ischemic insult and cytotoxic edema forma-
tion play a more important role in TBI-related brain swelling
and ICP increase than vascular engorgement and increase in
CBF (90).
SPREADING DEPOLARIZATION-INDUCED
CEREBROMICROVASCULAR DYSFUNCTION: ROLE IN
SECONDARY INJURY IN TBI
Characteristics of Spreading Depolarization Events and
Their Role in Dysregulation of CBF
There is growing evidence that spreading depolarizations
(SD), propagating waves of depolarization across the gray
matter, contribute to cerebral microvascular dysfunction and
pathogenesis of secondary neuronal injury after TBI. SDs
recurrent in injured tissue cause a dramatic disruption of ionic
homeostasis (58, 128), dendritic beading and swelling of neu-
rons and astrocytes (119, 120, 131), glucose depletion and
accumulation of lactate leading to tissue acidosis (44, 67, 122,
124), the release of glutamate together with related neuronal
calcium load (69), and typical changes in local CBF (12).
Regarded originally as an experimental curiosity, spontane-
ously generating SD has proven to be a potent pathogenic
mechanism in neurological diseases such as migraine with
aura, subarachnoid hemorrhage, ischemic stroke, and TBI (32).
Fig. 4. Proposed mechanisms underlying impaired myogenic autoregulatory
protection after TBI: TBI-induced impaired myogenic constriction. The mech-
anisms of the dysfunction of pressure-induced constriction are less known. For
detailed description of these pathways, we refer to the text.
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It has been recognized that SDs establish the initial damage
of the ischemic core and secondary lesion growth in the
penumbra of focal ischemia (62). The initial mass tissue
depolarization that follows the drop of CBF below a critical
threshold (5–10 ml/100 g/min) with a short delay (i.e., 2–5
min) is a persistent SD, which defines the primary infarction.
Subsequently, additional repetitive SDs recur spontaneously
for hours or days in the penumbra region (35, 61, 133), where
insufficient perfusion sets the scene for a critical supply-
demand mismatch to trigger SDs (147). These later SDs
propagate slowly (1–8 min/mm) across the cortex and convert
electrically silent but viable penumbra tissue into the core
region, thereby expanding the infarcted zone. Recent clinical
studies have shown that SD emerges as a potent pathomecha-
nism of the progression of secondary injury in TBI, as well (63,
65, 68).
The characteristic features of SD are a large transient neg-
ative shift in the slow electrical or direct current (DC) potential
and the simultaneous silencing of brain electrical activity
termed spreading depression (Fig. 5A) (52, 87). The SD-related
negative shift of the DC potential represents the complete loss
of resting membrane potential to a near 0 mV, reflecting an
increase of extracellular K from 3–4 to 30–60 mM, and the
concomitant decrease of the extracellular concentration of Na
from 140–150 to 50–70 mM and of Ca2 from 1–1.5 to
0.2–0.8 mM (115). At the level of the brain tissue, SD is an
intense self-igniting local depolarization of a critical mass of
cells, which propagates to adjacent cell populations in the
cerebral gray matter by means of increasing extracellular K
or glutamate concentration (128).
In the rat, the physiological pattern of SD-associated CBF
response includes four sequential components: 1) an initial
brief drop of CBF; 2) a marked transient peak hyperemia; 3) a
less obvious late hyperemia; and 4) a sustained hypoperfusion
also known as spreading oligemia (12). The share of these four
elements in the CBF response is variable, with the peak
hyperemic element being the most conspicuous. The hyper-
emic component is comparable to functional hyperemia of
physiological neurovascular coupling, since it supplies the
brain tissue with energy substrates to be used by ion exchange
pumps for the restoration of resting membrane potential. Com-
prehensive analysis and comparison of the CBF response in the
rat and patients revealed a good correspondence (109). There-
fore, data obtained from rat models have an accepted relevance
for human disease states.
In the ischemic brain, the CBF response to SD is more
dominated by vasoconstrictor mechanisms, and low perfusion
pressure further limits the extent of blood flow increase (44,
70). Thus, hyperemia is diminished while ischemic compo-
nents are more pronounced (100, 149). In the most severe
form, the vasoconstriction completely overrides dilatation (Fig.
5B) and causes pathological inverse neurovascular coupling,
known as spreading ischemia (32). This atypical SD-associated
CBF variation during ischemia aggravates metabolic supply-
demand mismatch in the tissue and can delay recovery from
SD. Longer cumulative SD duration, in turn, increases the
probability of neuronal cell death and eventually infarction (31,
32, 35).
The different phases of the SD-related CBF response are
assumed to be the result of a sequence and combination of
extracellular ionic, neurotransmitter, and metabolic changes
(12). These include, for example, interstitial K elevation,
variation in the release of NO or prostaglandins, or the mod-
ulation of adenosine receptors (12). Because of the complexity
of these interactions, it is rather challenging to discriminate the
significance of individual factors. Still, it has been suggested
that a high level of extracellular K exceeding 20 mM con-
centration (vasoconstrictor stimulus) in combination with de-
creased NO availability (permissive vasodilator agent) promote
vasoconstriction, and thereby trigger the shift to spreading
ischemia with SD (33, 148). These conditions are present in
TBI, since interstitial K is markedly elevated (118) and the
availability of NO may be limited by fast reaction with super-
oxide to form reactive nitrogen species (56). In addition, the
produced ONOO could promote vasoconstriction by the po-
tential inhibition of vascular Ca2-activated K channels (19),
as described above. Such pathophysiological conditions may
favor the development of spreading ischemia as a consequence
of SDs.
Fig. 5. The spreading depolarization (SD) phe-
nomenon as assessed at a single recording site
by direct current (DC) potential recording
(black trace) and alternating current (AC)-elec-
trocorticography (gray trace); and two distinct
types of associated CBF response (red trace)
acquired by laser Doppler flowmetry. Repre-
sentative traces are original recordings from the
rat brain. SD was elicited by the topical appli-
cation of high-concentration K in the young
intact (A) and the old ischemic (B) parietal
cortex.
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Evidence for the Occurrence and Injurious Potential of SD
in TBI Patients
The confirmation of SD occurrence in patients was delayed
for many years by the lack of an appropriate methodology. SD
propagation escaped detection on regular scalp EEG possibly
because bone and other tissue greatly alter the electrical signal,
and the frequency filtering, amplification, and time scale dis-
play of conventional EEG are not optimal to reveal SDs (36,
66). Thus, the first evidence for SD to occur in the neocortex
after TBI was obtained with invasive probes. Monitoring of
extracellular K concentration with a surface minielectrode in
the cortex, in combination with the assessment of local CBF
and tissue metabolism (tissue NADH levels), revealed recur-
rent SDs at the sampling site about every 30 min, leading to the
recording of 40 events in a comatose patient. These SDs
appeared as transient increases of interstitial K level, coupled
with typical hemodynamic responses resembling those previ-
ously seen with SDs in the rodent brain (94).
A more generalizable/applicable approach to monitoring SD
was then developed by adapting electrocorticographic (ECoG)
techniques used in epilepsy monitoring to the postoperative
monitoring of TBI. SD was originally discovered in rabbits as
transient abrupt reductions in ECoG amplitude acquired by
cortical surface electrodes (87). Thus, in a groundbreaking
study, Strong and colleagues placed ECoG electrode strips on
the cortical surface in patients who required surgery for trau-
matic intracranial hematoma. This study demonstrated that
spreading depression of the ECoG signal occurs commonly in
TBI patients (133). Subsequent studies then showed that the
spreading depressions are accompanied by the hallmark nega-
tive DC shift of SD.
DC shifts were first revealed as slow potential changes
recorded with alternating current (AC)-coupled amplifiers (41),
then by reconstruction of full-band DC-coupled recordings
from AC-coupled recordings (63), and finally by DC-coupled
electrocorticography (34). Recording the DC shift of SD is
recognized now as a required standard for identification of
these events, since it not only resolves ambiguous signals
but also reveals a subset of SDs that occur without spreading
depression of spontaneous activity (65). SD without spread-
ing depression occurs when spontaneous activity has already
been suppressed by ischemia or prior SDs and is termed
isoelectric SD.
Once reliable detection of SD in the injured human brain had
been established, subsequent studies aimed to determine the
incidence and time course of SDs, and conditions that may
favor SD elicitation (63). These studies showed that 55–60%
of surgical TBI patients develop SDs and that SDs often occur
in repetitive patterns through at least 7 days posttrauma (54, 56,
57). Lower levels of cerebral perfusion and high systemic
temperature are factors that increase the probability of SD,
likely through increased mismatch of energy supply-demand
(147), although the vast majority of SDs in TBI occur when
systemic variables are in normal ranges (63). Considering the
damaging effects of SD in ischemia, the potential of SD to
contribute to secondary injury in TBI patients was assessed. As
suspected, SDs with prolonged durations and those occurring
in association with isoelectricity or periodic epileptiform dis-
charges in the ECoG were predictive of unfavorable outcomes
(60, 65). Taken together, the clinical data confirmed that
recurrent SDs do occur spontaneously in the cortex of TBI
patients, and specific patterns of these events are independently
associated with worse clinical outcome.
An inadequate SD-associated CBF response can delay repo-
larization by depriving the tissue at risk of essential nutrients
required to restore ionic balance across neuronal cell mem-
branes (12, 32). This CBF response and the duration of depo-
larization are critical determinants of the harmful effects of SD,
since prolonged depolarization in metabolically compromised
tissue results in either infarction or selective neuronal necrosis
(62). To evaluate the CBF response to SD in patients with
aneurysmal subarachnoid hemorrhage, ECoG electrode strips
were also equipped with laser Doppler probes (34). With this
technique, spreading ischemia was commonly observed in the
human brain, often reducing CBF to ischemic levels. Thereaf-
ter, thermal diffusion probes were used alongside ECoG strips
for CBF monitoring in TBI patients, and inverse neurovascular
coupling was similarly observed (68). As in rodent models of
focal ischemia (127), inverse neurovascular coupling in TBI
patients was observed in the vicinity of evolving lesions,
occasionally during ongoing ischemic episodes (Fig. 6A), and
progressively reduced CBF in a stepwise fashion with each
successive SD (68).
Inverse coupling was additionally confirmed by the assess-
ment of the partial pressure of oxygen in the brain tissue in one
patient. The data revealed that the change in local partial
pressure of oxygen with SD transformed from physiological
transient hyperoxic response to inverse transient hypoxic re-
sponse over time (68). In addition, in this study, the inverse
CBF response with SD coincided with the loss of autoregula-
tion as assessed by correlations between CBF and mean arterial
pressure (Fig. 6B) (68). Importantly, the loss of autoregulation
after TBI, as mentioned above, is considered a risk factor for
ischemic damage following TBI. Speculatively, the ischemic
damage could result from transformation of hyperemic CBF
response to SD to spreading ischemia. The evolving char-
acteristics of SDs and impairment of autoregulation suggest
that continuous monitoring of these variables is important
for personalized diagnosis and treatment of secondary injury
(Fig. 7).
Evidence for the Occurrence of SD in Experimental Models
of TBI
SD waves were first demonstrated as a sequel of TBI in a rat
model of contusional injury induced by fluid percussion (135).
Although the genesis of SD was not universal (i.e., SDs were
shown in 6 of the 10 animals), the events were reliably detected
as recurrent transient negative shifts of the DC potential with
the concomitant depression of the ECoG. As expected for SD
waves, the negative DC shifts were also associated with tran-
sient increases of the interstitial K concentration (79). The
first SD occurred 1 h after impact, and subsequent SDs
occurred as often as 9–10 events/h (135). The experiments
were later extended by the assessment of regional CBF, using
[14C]iodoan tipyrine-based autoradiography (112). The analy-
sis of the autoradiograms indicated local transient hyperemic
CBF response to SDs, superimposed on a baseline CBF con-
siderably reduced by the contusion itself. The response was
blunted, however, since CBF barely exceeded baseline flow in
the hemisphere contralateral to the injury (112). The above
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Fig. 6. Inverse neurovascular coupling with
SD in a representative postoperative case of
TBI. A: bipolar electrocortigraphic (ECoG)
recordings: black traces depict SD (0.01 Hz
high-pass filtering); blue traces in the back-
ground represent spreading depression of ac-
tivity (0.5–50 Hz bandpass filtering). Syn-
chronous changes of regional cerebral blood
flow (rCBF) are shown in the red trace. Note
that rCBF drops with each subsequent SD
and returns to lower CBF after the passage
of each event. Blood pressure (BP) varia-
tions are represented by the gold trace.
B: gradual onset of impaired autoregulation
during the period of inverse coupling, as
demonstrated by the increasing correlation
between CBF and BP. Gray shaded area
indicates the range of correlation considered
to be significant, indicative of impaired au-
toregulation. C: brain images showing place-
ment of electrode (day 1 CT, blue arrow)
directly adjacent to an intracerebral hema-
toma where cortical lesions developed (day
11 MRI). Reproduced from Hinzman et al.
(68) with the permission of Oxford Univer-
sity Press (license no. 3816350088958).
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observations established without doubt that SD occurred spon-
taneously in the cortex after experimental TBI, with features
similar to SD events under cerebral ischemia. The conditions
leading to SD elicitation were not defined explicitly, but low
CBF in association with SD occurrence and high interstitial K
level related to the trauma and SDs were reported (108, 112).
It was not explicitly tested whether the SDs augmented injury,
although inverse CBF responses to SDs were occasionally
observed. Furthermore, the frequency and duration of SDs
recurrence were associated with the severity of brain injury
(121). Finally, high-frequency SD recurrence in combination
with ICP 20 mmHg was concluded to demonstrate advancing
secondary injury and poor outcome after TBI (121).
Although contusions are common with impact injuries, other
pathologies such as various types of intracranial hematoma
also prevail in severe TBI. Subdural hematoma, for instance, is
associated with high morbidity and mortality and causes injury
by raising intracranial pressure, compressing the brain, and
triggering a continuum of initial and subsequent SDs, as in
focal ischemia (64). SDs were also shown to emerge following
intracerebral hemorrhage in a swine model (105). Finally,
hemorrhage in the subarachnoid space, particularly following
hemolysis, can induce neural damage by provoking SDs and
scavenging NO, thereby promoting vasoconstrictive spreading
ischemia (33). These findings together suggest that hemor-
rhagic lesions in combination with contusions may account for
the high incidence of SD in patients with severe TBI (60, 64).
THERAPEUTIC POSSIBILITIES
At present there are no targeted interventions available to
restore autoregulatory function or prevent SDs and concomi-
tant CBF changes in humans with TBI. Current therapeutic
efforts focus on normalization of systemic hemodynamic pa-
rameters known to affect CBF regulation (blood pressure,
plasma osmotic pressure, plasma and erythrocyte volumes, and
PaO2 and PaCO2 using the so-called Lund protocol) to maintain
adequate perfusion of the injured areas (53).
On the basis of results from recent studies, a fairly novel
therapeutic approach emerged, namely maintaining the CPP at
a level where autoregulatory function is most preserved and
therefore optimal for the individual patient (20, 21, 25, 26, 86).
When the pressure reactivity index is monitored over a certain
period, it exhibits a U-shaped curve when plotted as a function
of CPP. The optimal CPP for the patient is then determined as
the value corresponding to the lowest PRx value of the curve.
This value can then be targeted in subsequent patient manage-
ment as a more personalized approach than simply maintaining
CPP within the broad range of 60–140 mmHg considered to be
normal for an adult population. The optimal CPP can in theory
be targeted more narrowly by ICP control and adjusting blood
pressure of the patient, thereby optimizing autoregulatory func-
tion. One study provided evidence for the efficacy of this
approach: smaller differences between optimal CPP and actual
CPP values maintained in patients throughout neurointensive
monitoring were associated with more favorable outcomes
(20). Actual CPPs that were well below optimal CPPs were
associated with higher mortality, and those substantially above
optimal CPPs were associated with increased disability (5,
132).
In animal models, 1 h posttraumatic hypothermia was shown
to improve TBI-related autoregulatory dysfunction in response
to sudden hypotension (48), but these promising results could
not be translated to clinical settings (4). As mentioned above,
in newborn pigs, administration of norepinephrine prevented
CBF reductions in response to decreasing blood pressure via
the inhibition of MAPKs (and probably via increasing perfu-
sion pressure) (10). Also, in piglets (9), glucagon treatment and
inhibition of tPA fully restored hypotension-induced pial arte-
rial dilation after FPI. Another interesting study demonstrated
that carbon-based antioxidant nanovectors (by annihilation of
ROS) targeted to P-selectin on injured cultured cerebral endo-
thelial cells decreased generation of superoxide (89). Further
studies should examine the possibility whether in vivo treat-
ment with these antioxidant clusters can restore autoregulation
of CBF. Also, further studies should examine whether targeting
the involved cellular pathways (Figs. 3 and 4) is capable of
preventing and/or treating dilatory dysfunction of cerebral
vessels during decreases in perfusion pressure. To restore
autoregulatory responses to increases in perfusion pressure,
further studies are needed to determine mechanisms of im-
paired myogenic constriction of cerebral vessels.
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requiring surgical alleviation of their symptoms. The insufficiency of the CBF
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thereby prolonging SD. Because longer SD duration has been associated with
larger injury, this chain of events is thought to contribute to the expansion of
secondary damage in TBI.
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